Sirtex appoints new CEO

By Ruth Beran
Thursday, 26 May, 2005

Sydney biomedical company Sirtex Medical (ASX:SRX) has promoted Gilman Wong from chief operating officer to chief executive officer.

Wong only joined Sirtex in February 2005 but chairman Bruce Gray said that he "has made a substantial contribution to company activities since then."

Wong has a strong background in sales and marketing -- a potentially useful background for Sirtex, whose sales revenue last year grew 8 per cent to $4.9 million, but whose gross profit fell to $3.57 million from $3.6 million in 2003.

Wong has held senior management positions in the manufacturing, engineering and automotive industries.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd